MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Basal Ganglia Germinoma (BGG) Presenting as Hemidystonia

    C. Ryan, R. Patel, S. Younes, M. Chintagumpala, N. Gadgil, M. Parnes (Houston, USA)

    Objective: We describe an unusual case of progressive right-sided hemidystonia with accompanying imaging and video. Background: Intracranial germinomas most often arise from midline structures, but…
  • 2026 International Congress

    Smell as a Diagnostic Signature: Systematic Review and Meta-Analysis of UPSIT Accuracy in Distinguishing Parkinson’s Disease from Essential Tremor

    M. Schiess, J. Martinez-Lemus, J. Rissardo, J. Patino, A. Caprara, A. Mcgarry, I. Walker (Houston, USA)

    Objective: To evaluate the diagnostic performance of the University of Pennsylvania Smell Identification Test (UPSIT) in differentiating Parkinson’s disease (PD) from essential tremor (ET) using…
  • 2026 International Congress

    Evaluating Magnetic Resonance Parkinsonism Index (MRPI) and MRPI 2.0 as Radiographic Metrics to Differentiate Progressive Supranuclear Palsy (PSP) from Normal Pressure Hydrocephalus (NPH)

    R. Mani, M. Murphy, C. Zheng, C. Pol, M. Egnor, G. Schwartz (Stony Brook, USA)

    Objective: We analyze the discriminatory diagnostic value of the Magnetic Resonance Parkinsonism Index (MRPI) and MRPI 2.0 in progressive supranuclear palsy (PSP) and normal pressure…
  • 2026 International Congress

    Anti-IgLON5 Encephalitis Presenting as Chronic Progressive Asymmetrical Ataxia and Chorea

    P. Kosiyakul, J. Jitprapaikulsan, Y. Pitakpatapee (Bangkok, Thailand)

    Objective: To report a case of gait instability and progressive asymmetrical chorea clinically confirmed as anti-IgLON5 encephalitis. Background: Anti-IgLON5 encephalitis is a rare autoimmune neurological…
  • 2026 International Congress

    Demystifying the Delivery of Multi-arm Multi-stage Platform Trials for Parkinson’s Disease –Framework and Recommendations from EJS ACT-PD

    C. Girges, J. Inches, L. Brennan, G. Mills, M. Zeissler, E. de Pablo-Fernandez, C. Pugh, C. Gonzalez-Robles, R. Gurney, S. Collins, C. Murphy, C. Carroll, T. Foltynie (London, United Kingdom)

    Objective: To develop a framework of protocol-aligned rater training, educational resources, and inter-site engagement (Stage 1). The secondary aim was to assess the perceived usefulness…
  • 2026 International Congress

    Investigating Phospho-α-Synuclein Pathology in Patient-Specific Microglia Integrated into Midbrain Organoids

    E. Zuccoli, H. Kurniawan, JC. Schwamborn (Esch-sur Alzette, Luxembourg)

    Objective: This study aims to determine how patient-specific microglia influence phospho-α‑synuclein aggregation and contribute to disease-relevant phenotypes within human midbrain organoids. Background: Parkinson’s disease (PD)…
  • 2026 International Congress

    Gut Barrier Failure In Parkinson Disease: Reduced Colonic Resilience In Moderate Disease And Spontaneous Pan-Intestinal Leak In Severe Disease

    M. Abdel-Mohsen, M. Shaikh, L. Zhang, P. Engen, C. Neumann, M. Villanueva, D. Sanchez-Bass, L. Dibenedetto, S. Luo, B. Killinger, C. Soto, S. Green, L. Lagorio, R. Voigt, A. Sharma, C. Goetz, A. Keshavarzian (Chicago, USA)

    Objective: To determine whether intestinal barrier dysfunction in Parkinson disease (PD) is stage-specific by assessing baseline epithelial permeability and resilience to inflammatory and microbial stressors.…
  • 2026 International Congress

    Holistic Sensor-Based Profiling of Parkinson’s Disease via Mixed Reality: Implementation and Multimodal Feasibility

    W. Szecowka, M. Wojcik-Pedziwiatr, M. Baran, J. Stepien, P. Jemiolo, N. Bozetine, M. Dudek, J. Krzywdziak, M. Zbik, D. Hemmerling, M. Rudzynska-Bar (Kraków, Poland)

    Objective: To validate a novel multimodal mixed-reality (MR) platform utilizing HoloLens 2 for the automated assessment of Parkinson’s disease (PD) symptoms and to determine the…
  • 2026 International Congress

    Machine Learning–Based Brain Age Modeling Reveals Accelerated Structural Degeneration in Parkinson’s Disease

    ZK. Liu, BX. Liu, MJ. Fang, N. Zhou, RT. Li, LC. He, ZT. Hu, WH. Li (Beijing, China)

    Objective: To compare the rate of global brain structural degeneration between healthy controls (HC) and patients with Parkinson’s disease (PD). Background: Normal aging is accompanied…
  • 2026 International Congress

    Pain relief beyond motor cortex modulation: clinical–neurophysiological dissociation after M1-tDCS in Parkinson’s disease

    A. Megía-García, Y. González Zamorano, F. Sanchez Cuesta, J. Gómez Soriano, J. Romero Muñoz (Toledo, Spain)

    Objective: To analyze the correlation between changes in pain-related outcomes and neurophysiological cortical measures following transcranial direct current stimulation (tDCS) in Parkinson’s disease (PD). Background:…
  • « Previous Page
  • 1
  • …
  • 32
  • 33
  • 34
  • 35
  • 36
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley